The treatment of pulmonary atresia consists of administration of an IV medication called
prostaglandin E1, which is used for treatment of pulmonary atresia by stopping the
ductus arteriosus from closing. This allows mixing of blood from the pulmonary and systemic circulations. Prostaglandin E1 can also be dangerous, however, as it can cause
apnea. Another example of preliminary treatment is
heart catheterization to evaluate the defect(s) of the heart; this procedure is much more invasive. Ultimately, however, the individual will need to have a series of surgeries to improve the blood flow permanently. The first surgery will likely be performed shortly after birth. A
shunt can be created between the aorta and the pulmonary artery to help increase blood flow to the lungs. As the child grows, so does the heart and the shunt may need to be revised in order to meet the body's requirements. The type of surgery recommended depends on the size of the
right ventricle and the
pulmonary artery. If the right ventricle is small and unable to act as a pump, the surgery performed would be the
Fontan procedure. In this three-stage procedure, the
right atrium is disconnected from the pulmonary circulation. The systemic venous return goes directly to the lungs, bypassing the heart. Very young children with elevated pulmonary vascular resistance may not able to undergo the Fontan procedure. Cardiac catheterization may be done to determine the resistance before going ahead with the surgery. ==Prognosis==